Clinical Trial Update: Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating fruquintinib in combination with TAS-102 for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN